Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Czock

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|October 27, 2006
Pharmacodynamic dose adjustment in renal failure: importance of the Hill coefficientD Czock
Der Radiologe|February 7, 2019
[Pharmacokinetics of gadolinium-based contrast agents]D Czock
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
The area under the effect-time curve as a target parameter for dosage adaptation in renal insufficiencyD Czock, F Keller
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
Pharmacodynamic half-life and effect-time course in renal impairmentF Keller, D Czock
International Journal of Clinical Pharmacology and Therapeutics|October 1, 1995
Aminoglycoside pharmacokinetics and -dynamics: a nonlinear approachD Czock, M Giehl
International Journal of Clinical Pharmacology and Therapeutics|December 16, 1998
Pharmacokinetic studies in volunteers with renal impairmentF Keller, D Czock
Clinical Pharmacokinetics|May 10, 2000
A concept for pharmacokinetic-pharmacodynamic dosage adjustment in renal impairment: the case of aminoglycosidesD Czock, M Giehl, F Keller
International Journal of Clinical Pharmacology and Therapeutics|September 12, 2006
Nephro-pharmacologyF Keller, U Ludwig, D Czock
Deutsche Medizinische Wochenschrift (1946)|September 7, 2005
[Chemotherapy in patients with renal failure, dialysis and after transplantation]F M Rasche, F Keller, D Czock
International Journal of Clinical Pharmacology and Therapeutics|April 30, 1998
Relationship between pharmacokinetic half-life and pharmacodynamic half-life in effect-time modelingF Keller, D Czock, D Zellner, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Clinical Pharmacology and Therapeutics|October 27, 2006
Pharmacodynamic dose adjustment in renal failure: importance of the Hill coefficientD Czock
Der Radiologe|February 7, 2019
[Pharmacokinetics of gadolinium-based contrast agents]D Czock
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
The area under the effect-time curve as a target parameter for dosage adaptation in renal insufficiencyD Czock, F Keller
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
Pharmacodynamic half-life and effect-time course in renal impairmentF Keller, D Czock
International Journal of Clinical Pharmacology and Therapeutics|October 1, 1995
Aminoglycoside pharmacokinetics and -dynamics: a nonlinear approachD Czock, M Giehl
International Journal of Clinical Pharmacology and Therapeutics|December 16, 1998
Pharmacokinetic studies in volunteers with renal impairmentF Keller, D Czock
Clinical Pharmacokinetics|May 10, 2000
A concept for pharmacokinetic-pharmacodynamic dosage adjustment in renal impairment: the case of aminoglycosidesD Czock, M Giehl, F Keller
International Journal of Clinical Pharmacology and Therapeutics|September 12, 2006
Nephro-pharmacologyF Keller, U Ludwig, D Czock
Deutsche Medizinische Wochenschrift (1946)|September 7, 2005
[Chemotherapy in patients with renal failure, dialysis and after transplantation]F M Rasche, F Keller, D Czock
International Journal of Clinical Pharmacology and Therapeutics|April 30, 1998
Relationship between pharmacokinetic half-life and pharmacodynamic half-life in effect-time modelingF Keller, D Czock, D Zellner, et al.
Pageof 3